3.34
Protara Therapeutics Inc Aktie (TARA) Neueste Nachrichten
Protara Therapeutics Inc. Stock Analysis and ForecastSuperior stock selection - Autocar Professional
What drives Protara Therapeutics Inc. stock priceUnmatched market performance - jammulinksnews.com
Is Protara Therapeutics Inc. a good long term investmentRapid growth trajectories - jammulinksnews.com
Protara Therapeutics (NASDAQ:TARA) Shares Up 11% – Still a Buy? - Defense World
What analysts say about Protara Therapeutics Inc. stockTremendous portfolio expansion - jammulinksnews.com
Best Banking Stocks AI Stock ForecastsRapidly expanding wealth - PrintWeekIndia
What analysts say about Arvinas Inc. stockFree Stock Movement Tracking - jammulinksnews.com
Is Armada Hoffler Properties Inc. a good long term investmentExplosive earning power - jammulinksnews.com
DGICB Stock Analysis and ForecastSkyrocketing investment returns - jammulinksnews.com
Will Protara Therapeutics Inc. stock split in the near futureDaily Top Gainers - Newser
Why Protara Therapeutics Inc. stock attracts strong analyst attentionFree Capital Allocation Plans - beatles.ru
What makes Protara Therapeutics Inc. stock price move sharplyMinimized Risk Trading Plan - Newser
How Protara Therapeutics Inc. stock performs during market volatilityStable Stocks With High Yield - Newser
Protara Therapeutics Awards 44,250 Equity Grants Worth $2.80 Per Share to Strategic New Hires - Stock Titan
TARA SEC FilingsProtara Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Protara Therapeutics, Inc.(NasdaqGM: TARA) added to Russell 3000E Index - MarketScreener
Protara Therapeutics, Inc. Added to Russell 3000® Index, Enhancing Visibility in Financial Community - Nasdaq
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Average Rating of “Buy” by Brokerages - Defense World
Protara Therapeutics (TARA) Drops 3.69% to 2024 Low - AInvest
Non-Muscle Invasive Bladder Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics - The Globe and Mail
Why EchoStar Stock Is Soaring Higher Today - The Globe and Mail
Two Sigma Investments LP Cuts Stock Holdings in Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World
Protara Therapeutics: Marching On To A Hopefully Eventful Back Half Of 2025 (NASDAQ:TARA) - Seeking Alpha
SoundHound AI (SOUN): This High-Potential Growth Stock Could Be Your Smartest Bet under $10 - The Globe and Mail
Where Will Uber Stock Be in 5 Years? - The Globe and Mail
Company News for Jun 13, 2025 - The Globe and Mail
Protara Therapeutics: Clinical Milestones and Robust Liquidity Fuel Near-Term Upside - AInvest
Protara Therapeutics Holds Annual Stockholders Meeting - TipRanks
These 3 ‘Bro Billionaire’ Stocks Are Wildly Outperforming in Trump’s Market - The Globe and Mail
Kantar appoints Jeff Greenspoon as CEO, Americas - The Globe and Mail
Cantor Fitzgerald Forecasts TARA FY2026 Earnings - Defense World
Squarepoint Ops LLC Makes New $110,000 Investment in Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World
Steven Hudson buying at ECN Capital (ECN) - The Globe and Mail
Protara Therapeutics, Inc. (NASDAQ:TARA) Position Increased by Bank of America Corp DE - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):